Biosynthetic Nanobubble-Mediated CRISPR/Cas9 Gene Editing of Cdh2 Inhibits Breast Cancer Metastasis
Overview
Affiliations
The epithelial-mesenchymal transition (EMT), a process in which epithelial cells undergo a series of biochemical changes to acquire a mesenchymal phenotype, has been linked to tumor metastasis. Here, we present a novel strategy for knocking out the EMT-related Cdh2 gene, which encodes N-cadherin through CRISPR/Cas9-mediated gene editing by an ultrasound combined with biosynthetic nanobubbles (Gas Vesicles, GVs). Polyethyleneimine were employed as a gene delivery vector to deliver sgRNA into 4T1 cells that stably express the Cas9 protein, resulting in the stable Cdh2 gene- knockout cell lines. The Western blotting assay confirmed the absence of an N-cadherin protein in these Cdh2 gene-knockout 4T1 cell lines. Significantly reduced tumor cell migration was observed in the Cdh2 gene-knockout 4T1 cells in comparison with the wild-type cells. Our study demonstrated that an ultrasound combined with GVs could effectively mediate CRISPR/Cas9 gene editing of a Cdh2 gene to inhibit tumor invasion and metastasis.
Emerging Gene-editing nano-therapeutics for Cancer.
Nujoom N, Koyakutty M, Biswas L, Rajkumar T, Nair S Heliyon. 2024; 10(21):e39323.
PMID: 39524822 PMC: 11550658. DOI: 10.1016/j.heliyon.2024.e39323.
Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research.
Pont M, Marques M, Sorolla M, Parisi E, Urdanibia I, Morales S Cancers (Basel). 2023; 15(17).
PMID: 37686639 PMC: 10486929. DOI: 10.3390/cancers15174364.
Nanoparticles in Medicine: Current Status in Cancer Treatment.
Pavelic K, Kraljevic Pavelic S, Bulog A, Agaj A, Rojnic B, colic M Int J Mol Sci. 2023; 24(16).
PMID: 37629007 PMC: 10454499. DOI: 10.3390/ijms241612827.
The CRISPR/Cas9 System Delivered by Extracellular Vesicles.
Zhu X, Gao M, Yang Y, Li W, Bao J, Li Y Pharmaceutics. 2023; 15(3).
PMID: 36986843 PMC: 10053467. DOI: 10.3390/pharmaceutics15030984.